Dr. Prashant Mehta

Home/Doctor/Dr. Prashant Mehta
Dr. Prashant Mehta
  • Name Dr. Prashant Mehta
  • DesignationConsultant - Medical Oncology/Hematology & Unit Head- BMT
  • SpecialistCancer Treatment
Hospital Designation
Consultant – Medical Oncology/Hematology
Unit Head- BMT
Qualification
  • MBBS – Maulana Azad Medical College , New Delhi
  • MD (Medicine)
  • DM, Medical Oncology (AIIMS, New Delhi)
  • European Society for Medical Oncology certification for excellent knowledge in the field of Medical Oncology
Experience
  • Consultant in Department of Medical Oncology/Hematology/BMT from January 2015 to June 2016 at Artemis Health Institute, Gurgaon
  • DM (Medical Oncology) in Department of Medical Oncology and Bone Marrow Transplant  from Jan 2012 to Dec 2014 at All India Institute of Medical Sciences, New Delhi
  • Senior Resident in Department of Medical Oncology and Bone Marrow Transplant from Aug 2010 to Dec 2012 at All India Institute of Medical Sciences, New Delhi
Achievements

International presentations

  • Invited as a Presenter at ESH International Conference on ACUTE MYELOID LEUKEMIA “Molecular and Translational” Advances in Biology and Treatment Budapest, Hungary in September 10-12, 2015
  • Chairs: B. Löwenberg, H. Döhner, M. Tallman
  • Oral presenter at Preceptorship on Prostate Cancer Barcelona in October 2015, conducted by European Society for Medical Oncology
  • Oral presenter at the prestigious ESMO Asia conference in Singapore in Dec, 2015  ( Work on Acute Myeloid Leukemia)
  • Oral presenter at preceptorship meeting on colorectal cancer in March 2015, Singapore
  • Has a number of publications in National and International journals to his credit
Speciality Interest
  • Treatment of  Solid Cancers in Adults and Children (Breast cancer, Prostate Cancer,  Lung Cancer, Ovarian Cancer, Colorectal Cancer, Renal Cell Carcinoma, Soft tissue Sarcomas, Melanoma, Ewing Sarcoma, Rhabdomyosarcoma)
  • Treatment of  hematolymphoid neoplasms and disorders  (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Bone Marrow Transplant/Stem cell transplant, Acute Myeloid LeukemiaNK/T cell lymphomaDLBCL-ABC type
  • Heated Intraperitoneal Chemotherapy (HIPEC)
  • Targeted therapy
  • Immunotherapy
  • Precision oncology
Membership
  • European Society of Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)
  • Society of Medical Oncology of India (SOMOI)
  • Indian Cooperative oncology Network (ICON)
  • Core committee member of Molecular Oncology working group of ICON
OPD Timings
  • Mon – Sat: 10:30 am – 2:00 pm